ALBT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Avalon Globocare Corp (ALBT) is not a good buy for a beginner, long-term investor with $50,000-$100,000 available. The stock shows a declining trend in price, weak financial performance, and no positive catalysts or trading signals to support a buy decision. Given the lack of momentum and poor fundamentals, it is better to avoid this stock at the moment.
The MACD is negatively expanding (-0.00444), RSI is at 37.151 (neutral zone), and moving averages are converging, indicating no clear upward trend. The stock is trading below key support levels (S1: 0.734), suggesting further downside potential.
NULL identified. No recent news or significant trading trends from hedge funds or insiders.
The stock price has declined significantly (-9.35% in regular market, -2.30% pre-market, -1.10% post-market). Financial performance shows a sharp decline in net income (-84.86% YoY) and EPS (-96.70% YoY). Technical indicators suggest bearish momentum.
In Q3 2025, revenue increased by 1.43% YoY to $350,099, but net income dropped sharply by -84.86% YoY to -$254,268. EPS fell by -96.70% YoY to -0.06, and gross margin improved to 33.06%, up 14.51% YoY. Overall, financials indicate weak profitability and growth.
No analyst rating or price target changes available.
